SG11202110423UA - Anesthetic composition and method of anesthetizing the eye - Google Patents

Anesthetic composition and method of anesthetizing the eye

Info

Publication number
SG11202110423UA
SG11202110423UA SG11202110423UA SG11202110423UA SG11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA
Authority
SG
Singapore
Prior art keywords
anesthetizing
eye
anesthetic composition
anesthetic
composition
Prior art date
Application number
SG11202110423UA
Other languages
English (en)
Inventor
Martin Uram
Original Assignee
Martin Uram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/024239 external-priority patent/WO2019191200A1/en
Application filed by Martin Uram filed Critical Martin Uram
Publication of SG11202110423UA publication Critical patent/SG11202110423UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202110423UA 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye SG11202110423UA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962824207P 2019-03-26 2019-03-26
PCT/US2019/024239 WO2019191200A1 (en) 2018-03-27 2019-03-27 Method and formulation for producing anesthesia of internal aspect of eye wall by topical application
US16/811,798 US11096922B2 (en) 2018-03-27 2020-03-06 Anesthetic composition and method of anesthetizing the eye
PCT/US2020/022915 WO2020197816A1 (en) 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye

Publications (1)

Publication Number Publication Date
SG11202110423UA true SG11202110423UA (en) 2021-10-28

Family

ID=72609654

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110423UA SG11202110423UA (en) 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye

Country Status (11)

Country Link
EP (1) EP3946311A4 (ko)
JP (1) JP2022527621A (ko)
KR (1) KR20210143254A (ko)
CN (1) CN114072139A (ko)
AU (1) AU2020245203A1 (ko)
BR (1) BR112021019039A2 (ko)
CA (1) CA3134531A1 (ko)
IL (1) IL286624A (ko)
MX (1) MX2021011589A (ko)
SG (1) SG11202110423UA (ko)
WO (1) WO2020197816A1 (ko)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674852B2 (en) * 1992-05-06 1997-01-16 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
JP4436131B2 (ja) * 2001-11-21 2010-03-24 イオルテク ヒアルロン酸を安定化させる組成物
CN101695488B (zh) * 2009-11-05 2012-05-02 蚌埠丰原涂山制药有限公司 复方阿替卡因注射用冻干制剂及其制备方法
CN101721407B (zh) * 2009-11-23 2013-04-10 蚌埠丰原涂山制药有限公司 复方盐酸阿替卡因注射液及其制备方法
FR2968996B1 (fr) * 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
FR3036035B1 (fr) * 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
AU2016321254A1 (en) * 2015-09-08 2018-04-05 Viewpoint Therapeutics, Inc. Compounds and formulations for treating ophthalmic diseases
WO2018220283A1 (fr) * 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine

Also Published As

Publication number Publication date
MX2021011589A (es) 2021-12-15
EP3946311A1 (en) 2022-02-09
EP3946311A4 (en) 2022-12-28
JP2022527621A (ja) 2022-06-02
IL286624A (en) 2021-10-31
BR112021019039A2 (pt) 2021-11-30
CA3134531A1 (en) 2020-10-01
CN114072139A (zh) 2022-02-18
AU2020245203A1 (en) 2021-11-11
KR20210143254A (ko) 2021-11-26
WO2020197816A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
IL283905A (en) Methods and preparations for transferring carbon dioxide
IL283840A (en) Preparations for administering therapeutic substances and methods for their use and preparation
IL287720A (en) modulators of thr-in the cell and methods of using them
IL276247A (en) Methods and materials for the treatment of sleep apnea
IL292810A (en) Therapeutic compounds and methods of use
IL276148A (en) A preparation and method for reducing platelet count through the administration of palinabolin
IL287966A (en) Automatic injector and associated methods of use
IL287796A (en) Preparations and methods for the treatment of diseases mediated by ATPase
IL285197A (en) Methods and preparations for the treatment of sleep apnea
HUE062202T2 (hu) Nyújtott hatóanyagleadású fájdalomcsillapító készítmények, és eljárás azok elõállítására
SG11202100533VA (en) Hepato-biliary-pancreatic tissues and methods of making same
IL286697A (en) Neurogulin-4 compounds and methods of use
IL284082A (en) Silk-hyaluronic acid tissue fillers and methods for their preparation and use
IL287829A (en) Progranulin modulators and methods of using them
IL276792A (en) Inhaler and methods for using it
IL277156A (en) Preparations and methods for treating insulin resistance
IL286624A (en) Anesthesia preparation and eye anesthesia method
GB202115731D0 (en) Compounds and methods of use
GB2579687B (en) Composition and method
EP3875135A4 (en) ANESTHESIA VENTILATION DEVICE AND PROCEDURE
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
IL282671A (en) Therapeutic methods and compositions
IL290548A (en) Bacteria and methods of using them
AU2019900514A0 (en) Compositions and methods for treating respiratory diseases
GB201908573D0 (en) Compounds and methods of use